Hovione executives Jean-Luc Herbeaux and Guy Villax stand in front of their booth at CPhI in Milan (Hovione PR)
After 25 years, Hovione's CEO will step down; Helsinn gains infigratinib license from BridgeBio
Hovione’s current COO will become its CEO on April 1.
The company announced that Guy Villax, the CEO for 25 years …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
